We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
-4.19%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.04B
AUM Growth
-$63.6M
Cap. Flow
-$14.6M
Cap. Flow %
-1.4%
Top 10 Hldgs %
44.54%
Holding
900
New
268
Increased
133
Reduced
141
Closed
310

Top Buys

Rank Stock Value
1
SLVM icon
Sylvamo
SLVM
+$64.9M
2
ARKK icon
ARK Innovation ETF
ARKK
+$54.7M
3
FULC icon
Fulcrum Therapeutics
FULC
+$48.9M
4
RIVN icon
Rivian
RIVN
+$32.4M
5
STOK icon
Stoke Therapeutics
STOK
+$22.5M

Sector Composition

Rank Sector Weight
1 Healthcare 39.85%
2 Financials 15.44%
3 Materials 6.54%
4 Consumer Discretionary 6.02%
5 Industrials 4.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANF icon
601
CALL
Abercrombie & Fitch
ANF
$5.24B
-21,600
Closed -$1K
ANF icon
602
Abercrombie & Fitch
ANF
$5.24B
-34
Closed -$1K
ANY icon
603
CALL
Sphere 3D
ANY
$18.7M
-177
Closed -$4K
APA icon
604
APA Corp
APA
$14.2B
-11,776
Closed -$317K
ASHR icon
605
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.58B
-19,221
Closed -$751K
ASHR icon
606
PUT
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.58B
-200,100
Closed -$22K
OPTU
607
Optimum Communications Inc
OPTU
$225M
-53,697
Closed -$869K
AXP icon
608
American Express
AXP
$230B
-8,966
Closed -$1.47M
AZN icon
609
AstraZeneca
AZN
$246B
-21,706
Closed -$2.53M
AZN icon
610
PUT
AstraZeneca
AZN
$246B
-28,150
Closed -$8K
BA icon
611
Boeing
BA
$184B
-7,469
Closed -$1.5M
BETRW icon
612
Better Home & Finance Warrant
BETRW
$1.85M
-132,215
Closed -$102K
BHP icon
613
BHP
BHP
$229B
-173,755
Closed -$9.35M
BIIB icon
614
PUT
Biogen
BIIB
$30.1B
-7,500
Closed -$42K
BNS icon
615
CALL
Scotiabank
BNS
$108B
-1,660,000
Closed -$5.84M
BNTX icon
616
BioNTech
BNTX
$23.3B
-1,490
Closed -$384K
BSX icon
617
CALL
Boston Scientific
BSX
$74.2B
-234,900
Closed -$29K
BSX icon
618
Boston Scientific
BSX
$74.2B
-139,530
Closed -$5.93M
BSX icon
619
PUT
Boston Scientific
BSX
$74.2B
-168,500
Closed -$50K
CAT icon
620
Caterpillar
CAT
$388B
-7,241
Closed -$1.5M
CFLT
621
CALL
DELISTED
Confluent
CFLT
-10,000
Closed -$91K
CLDX icon
622
Celldex Therapeutics
CLDX
$3.48B
-466,591
Closed -$18M
COF icon
623
CALL
Capital One
COF
$134B
-53,900
Closed -$103K
COF icon
624
PUT
Capital One
COF
$134B
-51,800
Closed -$6K
VISN
625
CALL
Vistance Networks Inc
VISN
$2.7B
-50,000
Closed -$4K

Similar funds

Cowen and Company's Q1 2022 Portfolio in Review

As of Q1 2022, Cowen and Company held 900 positions worth $1.04B, down 5.8% from $1.1B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Cowen and Company's Q1 2022 filing shows 268 new, 133 increased, 141 reduced and 310 closed positions. Its largest new stake was Sylvamo: 1,955,000 shares worth $65.1M. The largest sale was Invesco QQQ Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 26% a quarter earlier, followed by Financials and Materials.

  • Cowen and Company's largest Q1 2022 buy was Sylvamo: 1,955,000 shares worth $65.1M.
  • Cowen and Company added most to ARK Innovation ETF in Q1 2022, an estimated $54.7M increase.
  • Cowen and Company's biggest Q1 2022 reduction was Invesco QQQ Trust, cutting an estimated $143M.
  • Cowen and Company fully exited Churchill Capital Corp VI in Q1 2022, selling an estimated $34.2M.
  • Cowen and Company's ten largest holdings make up 45% of its $1.04B portfolio in Q1 2022.
  • Cowen and Company opened 268 new positions and closed 310 in Q1 2022.
  • Cowen and Company's portfolio value fell 5.8% quarter-over-quarter to $1.04B.

Based on Cowen and Company's 13F filing for Q1 2022, filed 16 May 2022.